当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第26期
编号:185533
补肾蠲毒丸联合恩替卡韦治疗免疫耐受期慢性HBV感染的效果
http://www.100md.com 2021年3月27日 中国医学创新 2021年第26期
     殷冬林 李姗

    【关键词】 补肾蠲毒丸 恩替卡韦 免疫耐受期 慢性HBV感染

    [Abstract] Objective: To investigate the effect of Bushen Juandu Pills combined with Entecavir in the treatment of chronic HBV infection in immune tolerance stage. Method: A total of 100 patients with chronic HBV infection in the immune-tolerant stage admitted to our hospital from January 2017 to March 2019 were selected, and they were divided into control group and study group according to random number table method, 50 cases in each group. The control group was treated with Entecavir, and the study group was treated with Bushen Juandu Pills on the basis of the control group. HBV-DNA negative conversion, HBeAg serum conversion, HBeAg negative conversion, efficacy, IL-10, IL-5, IFN-γ and serum fibrosis indexes were compared between two groups. Result: The total effective rate of the study group was higher than that of the control group ......

您现在查看是摘要页,全文长 13084 字符